Filings For: Silexion Therapeutics Corp
WHO USES CALCBENCH?    Equity Analysts    Corparate Finance & Reporting    Auditors    Academics

GO TO: Recent Comment Letters


Today


ALL   |    All 10-K/Qs   Large   Mid    Small    Micro    |     Earnings Release    Proxy    |   SORT BY :   Most Recent    Company Name 
CompanyTimeSizeViewFinancialsDocumentSECPeriodRevenue MRQAssetsEPS Diluted
Silexion Therapeutics Corp (SLXN) 8/25/2026 8:37:14 AM   View Proxy SEC Y 2025
Silexion Therapeutics Corp (SLXN) 8/14/2026 9:22:09 AM Micro View Financials 10-Q SEC 2Q 2026 ending: 6/30/2026 Assets $4,246,000 EPS $5.17
Silexion Therapeutics Corp (SLXN) 8/14/2026 9:02:05 AM   View Financials Earnings SEC 2Q 2026 Assets $4,246,000 EPS $5.17 Export Earnings Model
Silexion Therapeutics Corp (SLXN) 6/16/2026 4:44:52 PM   View Proxy SEC Y 2025
Silexion Therapeutics Corp (SLXN) 5/21/2026 4:02:00 AM Micro View Financials 10-K/A SEC Y 2025 ending: 12/31/2025 Assets $7,215,000 EPS $8.96
Silexion Therapeutics Corp (SLXN) 5/18/2026 8:33:56 AM   View Financials Earnings SEC 1Q 2026 Assets $4,602,000 EPS $0.85 Export Earnings Model
Silexion Therapeutics Corp (SLXN) 5/15/2026 5:31:07 PM Micro View Financials 10-Q SEC 1Q 2026 ending: 3/31/2026 Assets $4,602,000 EPS $0.85
Silexion Therapeutics Corp (SLXN) 4/9/2026 4:33:34 PM   View Proxy SEC Y 2025
Silexion Therapeutics Corp (SLXN) 3/17/2026 5:02:55 PM   View Financials Earnings WIRE Y 2025 Assets $7,215,000 EPS -$1.40 Export Earnings Model
Silexion Therapeutics Corp (SLXN) 3/17/2026 4:51:30 PM Micro View Financials 10-K SEC Y 2025 ending: 12/31/2025 Assets $7,215,000 EPS $8.96
Silexion Therapeutics Corp (SLXN) 2/23/2026 4:05:44 PM   View Proxy SEC Y 2025
Silexion Therapeutics Corp (SLXN) 11/12/2025 9:14:49 AM Micro View Financials 10-Q SEC 3Q 2025 ending: 9/30/2025 Assets $11,614,000 EPS $2.88
Silexion Therapeutics Corp (SLXN) 11/12/2025 9:07:30 AM   View Financials Earnings SEC 3Q 2025 Assets $11,614,000 EPS $2.88 Export Earnings Model
Silexion Therapeutics Corp (SLXN) 8/12/2025 4:14:07 PM Micro View Financials 10-Q SEC 2Q 2025 ending: 6/30/2025 Assets $5,797,000 EPS $4.32
Silexion Therapeutics Corp (SLXN) 8/12/2025 8:32:20 AM   View Financials Earnings SEC 2Q 2025 Assets $5,797,000 EPS $4.32 Export Earnings Model
Silexion Therapeutics Corp (SLXN) 7/31/2025 9:14:29 AM   View Proxy SEC Y 2024
Silexion Therapeutics Corp (SLXN) 6/16/2025 10:53:12 AM   View Proxy SEC Y 2024
Silexion Therapeutics Corp (SLXN) 5/13/2025 5:05:00 PM Micro View Financials 10-Q SEC 1Q 2025 ending: 3/31/2025
Silexion Therapeutics Corp (SLXN) 5/13/2025 4:57:10 PM   View Financials Earnings SEC 1Q 2025 Assets $8,308,000 EPS $0.26 Export Earnings Model
Silexion Therapeutics Corp (SLXN) 3/18/2025 4:44:09 PM   View Financials Earnings SEC Y 2024 Assets $2,863,000 EPS $20.76 Export Earnings Model
Silexion Therapeutics Corp (SLXN) 3/18/2025 4:33:28 PM Micro View Financials 10-K SEC Y 2024 ending: 12/31/2024
Silexion Therapeutics Corp (SLXN) 11/14/2024 9:05:04 AM   View Financials Earnings SEC 3Q 2024 Assets $3,087,000 EPS $2.03 Export Earnings Model
Silexion Therapeutics Corp (SLXN) 11/14/2024 8:41:49 AM Micro View Financials 10-Q SEC 3Q 2024 ending: 9/30/2024
Silexion Therapeutics Corp (SLXN) 10/22/2024 9:04:05 AM   View Proxy SEC
Silexion Therapeutics Corp (SLXN) 8/29/2024 4:55:20 PM Micro View Financials 10-Q SEC 2Q 2024 ending: 6/30/2024